Get Started
Breast Cancer Curricula
Step 1
Curriculum III
Curriculum II
These independent CME/CE activities are supported by educational grants from

Centocor Ortho Biotech Inc.

Genentech BioOncology.
Curriculum I
These independent CME/CE activities are supported by educational grants from Bristol-Myers Squibb

Genentech BioOncology

Novartis Pharmaceuticals Corporation



The Advanced Certificate Program in
Breast Cancer Management III
  1. Curriculum III
  2. Curriculum II
  3. Curriculum I
  4. Full Course List
Search by


Currently Available

Course Title Curriculum Faculty Release Date
Expert Insight Into: Anti-VEGF Monoclonal Antibody Plus Taxane-based Chemotherapy for Locally Recurrent or Metastatic Breast Cancer (Part 10 of Series) — Article Review (BC03.13) 1981.10 III Esteva Dec 2010
Expert Insight Into: Longer Therapy, Amenorrhea, and Breast Cancer (Part 9 of Series) — Article Review (BC03.11) 1981.09 III Burstein Nov 2010
Expert Insight Into: Prognostic and Predictive Value of a Multigene Tumor Assay in Postmenopausal Women with Node-Positive, Estrogen-Receptor–Positive Breast Cancer on Chemotherapy (Part 8 of Series) — Article Review (BC03.10) 1981.08 III Carey Nov 2010
Case Study: Hormone Receptor-Positive, HER2-Positive Metastatic Breast Cancer with Multiple Metastases — Tx Reporter e-Newsletter (BC03.12) 1982.02 III Burstein
Carey		 Nov 2010
Expert Insight Into: Open Label, Phase II Trial of an Irreversible ErbB Receptor Tyrosine Kinase Inhibitor in Patients with Advanced ErbB2-Positive Breast Cancer (Part 7 of Series) — Article Review (BC03.09) 1981.07 III Burstein Oct 2010
Breast Cancer Tumor Board Podcast — Podcast Series (BC03.08) 1983 III Burstein
Golshan
Bellon		 Sep 2010
Expert Insight Into: Selective Serotonin Reuptake Inhibitors and Breast Cancer Mortality in Women Receiving a Selective Estrogen Receptor Modulator (Part 6 of Series) — Article Review (BC03.07) 1981.06 III Carey Sep 2010
Expert Insight Into: The Combination of Two Anti-HER2 Monoclonal Antibodies in Patients with HER2-Positive Metastatic Breast Cancer that Progressed During Prior Therapy with One of These Agents. (Part 5 of Series) — Article Review (BC03.06) 1981.05 III Esteva Aug 2010
Expert Insight Into: Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving VEGF Inhibitors. (Part 4 of Series) — Article Review (BC03.05) 1981.04 III Burstein Aug 2010
Expert Insight Into: Aspirin Intake and Survival After Breast Cancer (Part 3 of Series) — Article Review (BC03.03) 1981.03 III Carey Jul 2010
Case Study: Refractory HER2-Positive Metastatic Breast Cancer — Tx Reporter e-Newsletter (BC03.04) 1982.01 III Burstein
Esteva		 Jul 2010
Expert Insight Into: Recurrence Score for Distant Recurrence Risk in Node-Negative/Node-Positive Postmenopausal Breast Cancer Patients Receiving Hormone Therapy (Part 2 of Series) — Article Review (BC03.02) 1981.02 III Burstein Jun 2010
Expert Insight Into: Prevention of Aromatase Inhibitor-Induced Bone Loss Using a Bisphosphonate: The SABRE Trial (Part 1 of Series) — Article Review (BC03.01) 1981.01 III Burstein Jun 2010
Expert Insight Into: A Human Epidermal Growth Factor Receptor 2 (HER2)-Specific Monoclonal Antibody Plus an Aromatase Inhibitor (AI) Versus an AI Alone for the Treatment of Postmenopausal Women with HER2–Positive/Hormone Receptor-Positive Metastatic Breast Cancer. — Article Review (BC02.13) 1906.06 II Gonzalez-Angulo Feb 2010
Expert Insight Into: High Risk of Recurrence for Breast Cancer Patients with HER2-Positive, Node-Negative Tumors 1 cm. or Smaller — Article Review (BC02.12) 1906.09 II Gonzalez-Angulo Jan 2010
Expert Insight Into: Patterns and Risk Factors Associated with Aromatase Inhibitor-Related Arthralgia Among Breast Cancer Survivors — Article Review (BC02.11) 1906.08 II Burstein Dec 2009
Expert Insight Into: Micrometastases or Isolated Tumor Cells and the Outcome of Breast Cancer — Article Review (BC02.09) 1906.10 II Gradishar Nov 2009
Case Study: Adjuvant Therapy in Hormone-Sensitive, HER2-Negative Breast Cancer — Tx Reporter e-Newsletter (BC02.10) 1907.02 II Burstein
Gradishar		 Nov 2009
Expert Insight Into: Survival Among Women with Triple Receptor-Negative Breast Cancer and Brain Metastases — Article Review (BC02.08) 1906.07 II Gonzalez-Angulo Oct 2009
Personalizing Breast Cancer Management: Update on Targeted Therapies and Molecular Diagnostics — Audio Interview Series (BC02.07) 1908 II Burstein
Smith		 Oct 2009
Expert Insight Into: Antitumor Activity of PARP Inhibitors in Tumors with BRCA Mutations — Article Review (BC02.06) 1906.05 II Dickler Sep 2009
Case Study: Triple-Negative Breast Cancer — Tx Reporter e-Newsletter (BC02.05) 1907.01 II Burstein
Dickler		 Aug 2009
Expert Insight Into: Association Between Polymorphisms in the VEGF and VEGFR-2 Genes and the Efficacy and Safety of Anti-VEGF Monoclonal Antibody in Patients with Advanced Breast Cancer — Article Review (BC02.04) 1906.04 II Dickler Aug 2009
Expert Insight Into: Whether to Continue HER2-Targeting Therapy After Disease Progression in Advanced Breast Cancer — Article Review (BC02.03) 1906.03 II Dickler Jul 2009
Expert Insight Into: Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer — Article Review (BC02.02) 1906.02 II Gradishar Jul 2009
Expert Insight Into: Endocrine Therapy plus a Bisphosphonate in Premenopausal Breast Cancer — Article Review (BC02.01) 1906.01 II Burstein Jul 2009
Fulvestrant, Exemestane Equivalent As Second-Line Treatment for Advanced Breast Cancer After AI Failure — Article Review (BC01.19) 1806.11 I Carey Jul 2008
Case Study: Neoadjuvant Systemic Therapy as a Standard in Breast Cancer — Tx Reporter e-Newsletter (BC01.18) 1807.04 I Burstein
Gradishar		 Jul 2008
Dose-Dense Adjuvant Therapy in the Treatment of Primary Breast Cancer — Audio Interview (BC01.17) 1808.03 I Burstein
Citron		 Jul 2008
Targeting the Microtubule: A Novel Approach to Treating Metastatic Breast Cancer — Webcast (BC01.20) 1832 I Burstein
Gradishar
Rugo		 Jul 2008
Case Study: Tumor and Patient Biomarkers as Predictors of Prognosis and Treatment Response — Tx Reporter e-Newsletter (BC01.16) 1807.03 I Burstein
Citron		 Apr 2008
Improving Treatment of Patients with Breast Cancer: The Case for an Expert Multidisciplinary Approach — Article Review (BC01.15) 1806.12 I Golshan Apr 2008
Reversing Estrogen Receptor-Negative Phenotype in Breast Cancer Can Restore Response to Antiestrogen Therapy — Article Review (BC01.14) 1806.10 I Gradishar Mar 2008
Genomic Changes in Tumor Stromal Cells Are Associated with Lymph Node Metastasis in Sporadic Breast Cancer — Article Review (BC01.13) 1806.09 I Burstein Mar 2008
Case Study: Targeted Adjuvant Therapy for HER2-Positive Breast Cancer — Tx Reporter e-Newsletter (BC01.12) 1807.02 I Burstein
Pegram		 Feb 2008
Measurement of Residual Breast Cancer Burden Can Predict Distant Relapse-free Survival — Article Review (BC01.11) 1806.08 I Citron Feb 2008
Age- and Race-Related Biological Characteristics of Breast Cancer — Audio Interview (BC01.09) 1808.02 I Pegram
Carey		 Jan 2008
MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer — Article Review (BC01.10) 1806.07 I Gradishar Jan 2008
New Strategies in Treating Women with Breast Cancer-Related Bone Metastases — Article Review (BC01.08) 1806.06 I Carey Jan 2008
Case Study: Adjuvant Systemic Therapy in Early Stage Breast Cancer — Tx Reporter e-Newsletter (BC01.07) 1807.01 I Pegram
Carey		 Dec 2007
Genetic Influences in Tumor Responses to Anti-VEGF Treatment — Article Review (BC01.06) 1806.05 I Pegram Nov 2007
Predictors of Response to Therapy — Audio Interview (BC01.05) 1808.01 I Burstein
Gradishar		 Nov 2007
New Chemotherapy Regimens for Older Patients with Node-Positive Breast Cancer — Article Review (BC01.04) 1806.04 I Gradishar Oct 2007
Expanding Role for Endocrine Therapy in Breast Cancer — Article Review (BC01.03) 1806.03 I Citron Oct 2007
Luteinizing Hormone-Releasing Hormone Agonists Broaden Treatment Choices for Premenopausal Breast Cancer Patients — Article Review (BC01.02) 1806.02 I Carey Sep 2007
Reviewing the Genetic Component — Article Review (BC01.01) 1806.01 I Burstein Aug 2007